Effective Integration of STI & HIV Prevention Programs

Similar documents
2011 STI Annual Report

2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential. STD Treatment Guidelines. How are the guidelines prepared?

Clinical Infectious Diseases Advance Access published September 1, 2015

There s an App for That: An Innovative Tablet-Based Sexual Health Application. Ashley Scarborough, MPH Linda Creegan MS, FNP

CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.

HPTN 073: Black MSM Open-Label PrEP Demonstration Project

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

Providing Optimal Care for Your MSM Patients

Estimates of New HIV Infections in the United States

Project AWARE Study Overview. Lisa Metsch, PhD Grant Colfax, MD Dan Feaster, PhD

DC Comprehensive HIV Prevention Plan for : Goals and Objectives

HIV Epidemiology in New York State

CDC 2015 STD Treatment Guidelines: What s new?

Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care

HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016

Men Who Have Sex With Men Have a 140-Fold Higher Risk for Newly Diagnosed HIV and Syphilis Compared With Heterosexual Men in New York City

Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon

TREATMENT OF STI CONTACTS

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011

Slide 1: Chlamydia and Gonorrhea: What You and Your Clients Need to Know. Welcome to Chlamydia and Gonorrhea: What You and Your Clients Need to Know.

Department of Veterans Affairs National HIV/AIDS Strategy Operational Plan 2011

STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT

California Guidelines for STD Screening and Treatment in Pregnancy

Understanding the HIV Care Continuum

Guidelines for Preventative Health Care in LGBT Populations

EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO

Developed by: California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch. In collaboration with:

Rhode Island Department of Health Division of Infectious Diseases and Epidemiology

Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013

Correlates of not receiving HIV care among HIV-infected women enrolling in a HRSA SPNS multi-site initiative

GONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)

Maryland HIV Plan

HIV Surveillance Update

ALAMEDA COUNTY, CALIFORNIA COMPREHENSIVE HIV PREVENTION PLAN

HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline

Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers

CME Article Hiv Disease Surveillance

Getting to Know PrEP (Pre-Exposure Prophylaxis)

HIV/AIDS in the Houston Area

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results

Frequently Asked Questions

Chlamydia trachomatis genital infection is the

Provincial Infectious Diseases Advisory Committee (PIDAC)

HIV Guidelines. New Strategies.

STI case management. Francis Ndowa - GFMER Theodora Wi - WHO

Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, 2004 Interim Progress Report

2010 STD Treatment Guidelines: Update for Primary Care Providers

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Exploring Cost and Delivery of STI Services by Health Departments in Georgia: A Mixed Methods Approach

Emerging Issues in Sexually Transmitted Diseases. Webinar. Managing STDs in Correctional Settings: Behind the Walls

Benjamin Tsoi, MD, MPH Director of HIV Diagnostics Bureau of HIV/AIDS Prevention and Control NYC Department of Health & Mental Hygiene

Partner Notification and Management Interventions

COMMUNICABLE DISEASE

HIV Prevention Through Early Detection and Treatment of Other Sexually Transmitted Diseases United States

Pre-exposure prophylaxis (PrEP)

Perspective Implications of the Affordable Care Act for People With HIV Infection and the Ryan White HIV/AIDS Program: What Does the Future Hold?

2013 STD/HIV Surveillance Report

Illustrating HIV/AIDS in the United States

EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE ELIGIBLE METROPOLITAN AREA PLANNING, PHILADELPHIA

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing

Targeted HIV Testing & Enhanced Testing Technologies. HIV Prevention Section Bureau of HIV/AIDS

Early mortality rate (EMR) in Acute Myeloid Leukemia (AML)

Outpatient/Ambulatory Health Services

SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS

Condoms for the prevention of HIV and STI transmission

STD Treatment Guidelines What s New?

GAO INDIAN HEALTH SERVICE. HIV/AIDS Prevention and Treatment Services for American Indians and Alaska Natives. Report to Congressional Requesters

UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report Sweden

HIV Continuum of Care Monitoring Framework 2014

TUBERCULOSIS (TB) SCREENING GUIDELINES FOR RESIDENTIAL FACILITIES AND DRUG

Transcription:

Effective Integration of STI & HIV Prevention Programs Jeanne Marrazzo, MD, MPH University of Washington, Seattle September 27, 2013

Key Points STIs are really common among those at highest risk of HIV This presents a uniquely focused opportunity to intervene with biobehavioral interventions Comprise evidence-based behavioral & newer biomedical interventions (PrEP, PEP, referral) IAS-USA Guidelines in development; anticipated release early 2014 STI are common and often remain undiagnosed in the HIV care setting

Data from 557 adults in a prospective cohort of contemporary HIV-infected adults in primary care in 4 cities Screened/treated for STD at enrollment and at 6 months 13% with STD at enrollment; 7% incident STD at 6 months Excluding trichomoniasis, 94% of incident STDs were in MSM Most common in men: rectal chlamydia, oropharyngeal gonorrhea Risks: polysubstance use, > 4 partners in 6 months 20% of MSM diagnosed with an STD by 6 months: most were asymptomatic Mayer et al. Sex Transm Dis 2012 3

STD Surveillance Network (SSuN) Proportion of MSM* Attending STD Clinics with Primary and Secondary Syphilis, Gonorrhea or Chlamydia by HIV Status, 2010 Percentage 20 16 HIV HIV+ 12 8 4 0 P&S syphilis GC urethral GC pharyngeal GC rectal CT urethral CT rectal * MSM = men who have sex with men. HIV negative status includes persons of unknown status for this analysis. GC urethral and CT urethral include results from both urethral and urine specimens. See also Ganesan 2012; Spaulding 2012: military cohort data

Barriers to Bacterial STI Screening of HIV+ Men who have Sex with Men in HIV Primary Care Settings Lindley A. Barbee, Shireesha Dhanireddy, Susana Tat, Amy Radford, Jeanne M. Marrazzo ISSTDR 2013 Vienna, Austria

Background CDC-funded initiative to increase bacterial STI screening among HIV+ MSM Seattle STD/HIV Prevention Training Center Madison Clinic HIV Primary Care Clinic 2,570 patients 81% Men 66% MSM University of Washington Ryan White Funded

Objectives 1) Quantify current STI testing coverage among MSM at Madison Clinic 2) Identify patient and provider related barriers to STI screening

Results: STI Testing Coverage 72% Syphilis serology 40% Urine GC/CT NAAT 1,456 MSM March 2011 September 2012 32% Throat GC (culture or NAAT) 29% Rectal GC/CT (culture or NAAT)

Methods: Patient Barriers Anonymous written survey Offered to all male patients in waiting room Over 3 week period in May 2012 110 HIV+ MSM responded

Results: Patient Survey (N=110) In the past two months: 69% sexually active in last 2 months Median of 1 sex partner (range 1-20) In the past 12 months: 16.4% methamphetamines use or IVDU 25.5% bacterial STI

Results: Care Seeking Choices (N=110) 28% seek STI care outside of HIV Primary Care 50% Why MSM Seek STD Testing Outside of HIV Primary Care 40% 30% 20% 10% 0% 42% 21% 16% "Easier" Anonymity More Frequent N=31 <3% <3% Cost Convenience

Methods: Provider Barriers Anonymous electronic survey All HIV care providers Residents, Fellows, Attending Physicians, ARNPs 28 / 33 (85%) responded 23 /28 (82%) attending physicians

Results: Provider Knowledge Barriers(n=28) 25% unaware of NAAT for extra-genital GC/CT 32% unsure of CDC STI screening guidelines 25% incorrectly identified the CDC recommended two-drug therapy when presented with a case of pharyngeal gonorrhea

Provider Reported Barriers to Routine STI Screening 80% 70% 60% 50% 40% 30% 68% 39% Of those reporting Patient Reluctance: 55% unprepared 82% test elsewhere 27% prefer same-sex provider 20% 21% 10% 0% Lack of time Patient reluctance Uncomfortable w sexual history/exam 7% 7% Unsure of how to collect specimens Lack of support (staff)

Results: Provider Suggestions for Improvement 82% tracking system 71% access to results from STD Clinic 57% self-collected specimens 32% individualized QI reports

Summary High-risk sexual activity is common among HIV+ MSM engaged in care Comprehensive STI screening remains low in HIV primary care Patients want easy, convenient and anonymous testing Many providers lack STI testing and treatment knowledge, are uncomfortable with sexual history & genital exam, and most are pressed for time.

Interventions to Overcome Barriers Provider Education Linkage to STD Clinic Results STI Self-Testing Program

STI Self-Testing Program 75 tested in first 3 months Complete testing data on 49 12 MSM with at least one STD (24.5%) 6 pharyngeal GC (13%) 5 rectal GC (12%) 4 syphilis (11%) 3 rectal CT (7%)

Population-based HIV Incidence among Men Diagnosed with Infectious Syphilis, 2000-2011 (Pathela et al) Objective: measure HIV incidence after P/S Σ Cases reported to HIV and STD surveillance registries were matched using a deterministic algorithm Measured annual HIV incidence among men following P&S syphilis diagnoses between January 2000-June 2010 Excluded men with known HIV at time of syphilis diagnosis, or within 60 days after Estimates for risk of new HIV diagnosis by key characteristics

Study Population 13-19 20-24 25-29 30-34 35-39 40-44 45-49 50+ White Black Hispanic Other MSM MSW Other risk Syphilis only Concurrent STD* Subsequent STD* 4 6 7 7 8 16 17 17 17 12 13 14 20 23 27 32 67 82 0 10 20 30 40 50 60 70 80 90 Percent of Syphilis Cases * Includes diagnoses of chlamydia, gonorrhea, and lymphogranuloma venereum

Follow-up for HIV 2,805 men with syphilis contributed 11,714 person-years of follow-up 423 (15.1%) subsequently acquired HIV Median time to HIV diagnosis was 582 days (range 60-3150)

Results HIV incidence P&S syphilis cases Newly diagnosed HIV Personyears at risk Annual HIV incidence (%) 95% CI (HIV incidence) Total 2805 423 11714.18 3.61 3.27-3.97 Age 13-19 178 35 646.12 5.42 3.83-7.45 20-24 449 73 1654.75 4.41 3.48-5.51 25-29 484 83 1897.18 4.37 3.51-5.40 30-34 472 80 2107.84 3.80 3.03-4.70 35-39 489 76 2284.96 3.33 2.64-4.14 40-44 345 43 1511.29 2.85 2.08-3.80 45-49 186 23 742.20 3.10 2.01-4.58 50+ 202 10 869.84 1.15 0.58-2.05 Race/ethnicity White 751 126 3064.03 4.11 3.44-4.88 Black 898 169 3597.64 4.70 4.03-5.45 Hispanic 642 94 2480.61 3.79 3.08-4.62 Other 222 34 960.85 3.54 2.49-4.89

Results - HIV incidence P&S syphilis cases Newly diagnosed HIV Personyears at risk Annual HIV incidence (%) 95% CI (HIV incidence) Sexual behavior/risk MSM 1884 389 7000.55 5.56 5.02-6.13 MSW 373 20 1661.05 1.20 0.76-1.83 Other, IDU, or unk 548 14 3052.57 0.46 0.26-0.75 Syphilis stage Primary 859 103 3905.50 2.64 2.16-3.18 Secondary 1946 320 7808.68 4.10 3.67-4.57 Bacterial infections Syphilis only 2310 281 9718.04 2.89 2.57-3.24 Syphilis w/concurrent STD* 103 12 348.96 3.44 1.86-5.85 Syphilis &

Implications On a population level, one in 20 NYC MSM with syphilis are diagnosed with HIV within a year Not likely much different from most urban settings currently experiencing syphilis epidemics in MSM Frequent HIV testing to detect AHI and HIV pre-exposure prophylaxis should be considered for HIV-negative syphilis cases